This inventor holds 1 USPTO granted patent. Top assignee: Nagoya Industrial Science Research Institute. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Minoru Hamazaki: Innovator in Cancer Cell Malignancy Assessment
Introduction
Minoru Hamazaki is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of cancer research, particularly in the assessment of malignancy in carcinoma cells. His innovative approach has the potential to enhance the accuracy of cancer diagnoses.
Latest Patents
Hamazaki holds a patent for a method of judging the grade of malignancy of carcinoma cells using ATBF-1. This method allows for the easy determination of the malignancy grade of cancer cells. The process involves detecting the amount of ATBF1 in the whole cell structure, nuclei, or cytoplasms of test cancer cells separated from a living organism. The detection results are then used to judge the malignancy grade of the test cancer cells.
Career Highlights
Minoru Hamazaki is affiliated with the Nagoya Industrial Science Research Institute, where he continues to work on innovative solutions in cancer research. His dedication to improving cancer diagnostics has positioned him as a key figure in his field.
Collaborations
Hamazaki has collaborated with notable colleagues, including Yutaka Miura and Makoto Kawaguchi. Their combined expertise contributes to the advancement of research in cancer cell assessment.
Conclusion
Minoru Hamazaki's work in developing methods for assessing the malignancy of carcinoma cells represents a significant advancement in cancer research. His innovative approach has the potential to improve diagnostic accuracy and patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile